Creating a Different Kind of Innovator: Using health communication theory in entrepreneurship education to foster behavior change among entrepreneurship students in sub-Saharan Africa

There is a broad scholarly consensus that entrepreneurship can be taught and that entrepreneurship education benefits societies (Charney & Libecap, 2003). However, technical entrepreneurship education interventions are still the norm in the West (Alberti & Poli, 2005), and especially in sub-Saharan Africa (North, 2002; Ladzani & van Vuuren, 2002). In this study, we argue that entrepreneurship education in sub-Saharan Africa follows a special pattern, and that health communication theory can inform improvements in enterprise training in the African context because of its particular effectiveness in inducing behavior change where environmental norms would normally constrain the development of such new behavior. The overall goal of the present paper is threefold; to contribute to the understudied domain of entrepreneurship education theory for economic development, to inform more effective enterprise training interventions in sub-Saharan Africa, and to foster the generation of more entrepreneurs capable of contributing to wealth generation in this region

Topical use of MMC in the upper aerodigestive tract: a review on the side effects

Not much is known about the side effects of mitomycin C (MMC), an anti-fibrogenetic agent, in the upper aerodigestive tract. However, its use in ophthalmology is widely known and without quantitatively important side effects. A literature review was performed for side effects of MMC in the upper aerodigestive tract. Forty-six articles, describing the use of MMC to prevent scarring, were retracted from PubMed. Thirty-two are human studies. MMC is used in different concentrations (0.1–10 mg/ml) with different application times (2–5 min) and frequencies (up to 4 times). Five hundred and thirty-eight patients were included in those publications, of whom 19 developed side effects (3.53%). No side effects developed in studies, where post-application irrigation with saline was reported. The longest mean follow-up period is 75.5 months. Direct relations between the reported side effects and MMC seem absent in most studies. Serious complications seem to occur when MMC is used in high concentrations. Unfortunately, sometimes crucial information is lacking. One patient was described who supposedly developed laryngeal carcinoma after repeated treatment of hyperkeratosis and anterior commissure webbing. Animal studies show that excessive fibrin production can lead to acute airway obstruction. In conclusion, topical application of MMC on a wound with consecutive irrigation with saline can be performed safely to prevent scar formation in circular structures of the upper aerodigestive tract. Long-term yearly control of the application site seems advisable

Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery

Peer reviewe

Big Data Ethics:

The adoption of big data analysis in the legal domain is a recent but growing trend that highlights ethical concerns not just with big data analysis, as such, but also with its deployment in the legal domain. This article systematically analyses five big data use cases from the legal domain utilising a pluralistic and pragmatic mode of ethical reasoning. In each case we analyse what happens with data from its creation to its eventual archival or deletion, for which we utilise the concept of ‘data life cycle’. Despite the exploratory nature of this article and some limitations of our approach, the systematic summary we deliver depicts the five cases in detail, reinforces the idea that ethically significant issues exist across the entire big data life cycle, and facilitates understanding of how various ethical considerations interact with one another throughout the big data life cycle. Furthermore, owing to its pragmatic and pluralist nature, the approach is potentially useful for practitioners aiming to interrogate big data use cases